Thursday, November 15, 2007
Print Current Session:
|
|
Thursday
SESSION X:
MORE TOPICS FOR INTERVENTIONISTS, CARDIAC SURGEONS AND VASCULAR SURGEONS ABOUT THORACIC ENDOGRAFTING (6-MINUTE FAST PACED TALKS)
Moderators:Bruce Lytle, M.D. , Frank J. Veith, M.D.
|
|
SESSION X SCHEDULE | |
7:51 AM - 7:57 AM | Debate: Hybrid Approaches To Thoracic Aortic Aneurysms (TAAs) Involving Arch Vessels: Extra-Anatomic Bypass Is Less Invasive And Best |
Presenters(s): Alan B. Lumsden, M.D., F.A.C.S. | |
7:58 AM - 8:04 AM | Debate: Direct Approach To TAAs Involving The Arch Vessels By The Elephant Trunk (Hybrid Technique) Is Best And More Durable |
Presenters(s): Lars G. Svensson, M.D., Ph.D | |
8:05 AM - 8:11 AM | Debate: Treatment Of Thoracoabdominal AAAs Will Be Most Effective If Accomplished With Fenestrated Grafts And Stent-Graft Branches |
Presenters(s): Roy K. Greenberg, M.D. | |
8:12 AM - 8:18 AM | Debate: Treatment Of TAAAs Will Be Most Effective If Accomplished With A Branched Main Body And Stent-Graft Extensions |
Presenters(s): Timothy A.M. Chuter, M.D. | |
8:19 AM - 8:25 AM | The INSTEAD Trial Update: What Is The Role Of Endografting Versus Medical Management In Uncomplicated Type B Dissections And What Factors Are Predictive Of A Dire Outcome And Justify Early Stent-Grafting? |
Presenters(s): Christoph A. Nienaber, M.D., Ph.D. | |
8:26 AM - 8:32 AM | Results With The Cook Zenith Dissection Device Featuring Covered And Uncovered Stent Portions For Treatment Of Type B Dissections |
Presenters(s): Joseph V. Lombardi, M.D. | |
8:33 AM - 8:39 AM | Fenestrated And Branched Stent-Grafts For Diffuse Aortic Arch Lesions: Techniques, Problems And Results |
Presenters(s): Krassi Ivancev, M.D., Ph.D. | |
8:40 AM - 8:46 AM | Long-Term (5-Year) Trial Results Of TAA Repair With The Gore TAG Endograft: Up To 45 mm In Diameter |
Presenters(s): Michel S. Makaroun, M.D. | |
8:47 AM - 8:53 AM | Updated Trial Results With The Cook Zenith TX 2 Endograft For Thoracic Aortic Pathology |
Presenters(s): Jon S. Matsumura, M.D. | |
8:54 AM - 9:00 AM | Results Of The VALOR Trial For Treatment Of Thoracic Aortic Lesions: Pivotal And High Risk Arms And VALOR II Design |
Presenters(s): Ronald M. Fairman, M.D. | |
9:00 AM - 9:12 AM | Panel Discussion |
END OF SESSION X |